- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04330404
Effects of Cognitive Strategy Training on Daily Function in People With Subjective Cognitive Decline
Subjective cognitive decline (SCD) is the transitional state between normal aging and mild cognitive impairment. SCD is defined as having self-perceived declines in any cognitive domain over time; having normal performance on cognitive testing; no dementia or depression. Cognitive difficulties can lead to a decline on daily function and quality of life. Early intervention can prevent SCD from developing into dementia.
Cognitive strategy training (CST) aims to generate individualized strategies to solve cognitive problems, which can be effective to improve daily functions and performances. However, there is limited clinical research aimed at improving daily functions for SCD. Most non-pharmacological studies have conducted objective cognitive training, which may not enhance daily performance. Previous studies also seldom examine the effectiveness of the intervention to improve daily function, quality of life, self-efficacy and motivation.
This study adopts a quasi-experimental design. The investigators will recruit 80 community-dwelling people with SCD who are aged 55 and older. There will be 40 participants in each group. The experimental group will receive the CST. The active control group will receive group interactive game. Both groups will have 8 sessions for one hour per week for a total of 8 weeks. Outcome measures include daily function, self-efficacy, motivation for change, and quality of life. Assessments will be performed at baseline, post-intervention, and 3-month follow-up. The demographic data of the two groups will be compared using the independent sample t-test and chi-square test. Changes on outcomes between the two groups will be analyzed by two-way ANOVA. This study was approved by the Human Research Ethics Committee at National Cheng Kung University. All participants provided written informed consent before testing.
This study aims to (1) examine the feasibility of the CST in community-dwelling people with SCD; (2) explore the efficacy of the CST on daily function, self-efficacy, motivation for change, and quality of life.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Tainan, Taiwan, 701
- Department of Occupational Therapy, College of Medicine, National Cheng Kung University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- aged 55 and above
- live in community
- self-perceived decline in cognition compared to five years ago
- subjective cognitive decline, Cognitive Failure Questionnaire (CFQ) score above zero.
Exclusion Criteria:
- objective cognitive impairment, Taiwanese version of the Montreal Cognitive Assessment (MoCA-T) scores below 24
- any medical, neurological or psychiatric disorders, Brief Symptom Rating Scale (BSRS-5) scores 10 or more
- severe visual, auditory, verbal or physical impairments interfere with communication, command compliance, and strategy execution
- participate in other research related to cognitive strategy at the same time.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Cognitive strategy training
The experimental group will receive the Cognitive strategy training (CST), which includes awareness enhancement, cognitive-related education, discussion of everyday cognitive difficulties, generation of cognitive strategies, cognitive strategy practice, and homework assignments.
|
The Cognitive strategy training, including awareness enhancement, cognitive-related education, discussion of everyday cognitive difficulties, generation of cognitive strategies, cognitive strategy practice, and homework assignments
|
Active Comparator: group interactive game
The active control group will receive group interactive game, including table games and games using songs, balloons, newspapers and so on.
|
The active control group will receive group interactive game, including table games and games using songs, balloons, newspapers and so on.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from Baseline Canadian Occupational Performance Measure-Chinese version (COPM-C) at post-intervention, and 3-month follow-up.
Time Frame: Assessments will be performed at baseline, within one week after the intervention, and 3-month follow-up after the intervention. .
|
Canadian Occupational Performance Measure-Chinese version (COPM-C) is a semi-structured interview questionnaire used to assess self-perceived problems in occupational performance areas. Participants need to identify cognitive-related occupational performance problems, then score the importance from 1 to 10. The higher the score, the more important it is. Participants also need to score their performance and satisfaction from 1 to 10 on the first five important issues. Higher scores mean a better outcome. |
Assessments will be performed at baseline, within one week after the intervention, and 3-month follow-up after the intervention. .
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from Baseline General Self-Efficacy Scale (GSE) at post-intervention, and 3-month follow-up.
Time Frame: Assessments will be performed at baseline, within one week after the intervention, and 3-month follow-up after the intervention.
|
General Self-Efficacy Scale (GSE) is a self-reported questionnaire used to assess individual beliefs of how effective they are in facing stress and challenges.
The scale scores range from 10 to 40, with higher scores indicating better self-efficacy.
|
Assessments will be performed at baseline, within one week after the intervention, and 3-month follow-up after the intervention.
|
Change from Baseline Contemplation ladder at post-intervention, and 3-month follow-up.
Time Frame: Assessments will be performed at baseline, within one week after the intervention, and 3-month follow-up after the intervention.
|
Contemplation ladder is an 11-point scale used to assess readiness and motivation for change before action.
The scale score is between 0 and 10, with higher scores indicating greater motivation for change.
|
Assessments will be performed at baseline, within one week after the intervention, and 3-month follow-up after the intervention.
|
Change from Baseline COOP/WONCA (World Organization of Family Doctors) charts at post-intervention, and 3-month follow-up.
Time Frame: Assessments will be performed at baseline, within one week after the intervention, and 3-month follow-up after the intervention.
|
COOP/WONCA (World Organization of Family Doctors) is a self-reported chart used to assess health-related quality of life.
The scale scores range from 6 to 30, with lower scores indicating better quality of life.
|
Assessments will be performed at baseline, within one week after the intervention, and 3-month follow-up after the intervention.
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Shuchen Liu, Department of Occupational Therapy, College of Medicine, National Cheng Kung University, Taiwan
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NCKU HREC-E-108-388-2
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Subjective Cognitive Decline
-
Beijing Hospital of Traditional Chinese MedicineUnknownSubjective Cognitive Decline | Subjective Cognitive ComplaintChina
-
University of WaterlooUniversity of Ottawa; Baycrest; Université de MontréalRecruiting
-
Vanderbilt University Medical CenterNot yet recruiting
-
Indiana UniversityNational Institute on Aging (NIA)CompletedSubjective Cognitive DeclineUnited States
-
Centre de Recherche de l'Institut Universitaire...Canadian Institutes of Health Research (CIHR); Rotman Research Institute at...Active, not recruitingSubjective Cognitive DeclineCanada
-
BaycrestCompletedSubjective Cognitive DeclineCanada
-
BaycrestCompletedSubjective Cognitive DeclineCanada
-
Evidation HealthNeurotrackCompleted
-
Fundacion Clinic per a la Recerca BiomédicaUnknownSubjective Cognitive Decline
-
Vanderbilt University Medical CenterRecruiting
Clinical Trials on Cognitive strategy training
-
Washington University School of MedicineCompleted
-
VA Office of Research and DevelopmentCompleted
-
Nova Scotia Health AuthorityCanadian Institutes of Health Research (CIHR); IWK Health CentreTerminatedStroke | Cognitive ImpairmentCanada
-
University of TorontoRecruitingPsychotic Disorders | Executive DysfunctionCanada
-
US Department of Veterans AffairsCompletedCognition DisordersUnited States
-
Amsterdam UMC, location VUmcNot yet recruitingGlioma | Cognitive ImpairmentNetherlands
-
YuanYuan MaRecruiting
-
Washington University School of MedicineCompleted
-
BaycrestCompletedSubjective Cognitive DeclineCanada
-
University of PittsburghRecruiting